Who is sponsoring NCT05114395?

NCT05114395 is sponsored by Centro Hospitalar De São João, E.P.E..

What drugs are being tested in NCT05114395?

Interventions in NCT05114395: Pelvic Floor Telerehabilitation Program, Pelvic Floor Face-to-Face Program.

What condition does NCT05114395 study?

NCT05114395 studies Stress Urinary Incontinence, Incontinence, Urinary, Covid19, Pelvic Floor Muscle Weakness.

Is NCT05114395 still recruiting?

NCT05114395 is currently completed. Last updated 10 November 2021.

Last reviewed 2021-11-10 · How we verify

NCT05114395

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between a Telerehabilitation Program for Urinary Incontinence Versus a Conventional Face-to-face Program

Completed NA Last updated 10 November 2021

What this trial tests

NA trial testing Pelvic Floor Telerehabilitation Program in Stress Urinary Incontinence in 39 participants. Completed in 9 August 2021.

Timeline

8 March 2021

Primary endpoint
12 July 2021

9 August 2021

Quick facts

Lead sponsor	Centro Hospitalar De São João, E.P.E.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	39
Start date	8 March 2021
Primary completion	12 July 2021
Estimated completion	9 August 2021
Sites	2 locations across Portugal

Drugs / interventions tested

Pelvic Floor Telerehabilitation Program
Pelvic Floor Face-to-Face Program

Conditions studied

Stress Urinary Incontinence — all drugs for Stress Urinary Incontinence →
Incontinence, Urinary — all drugs for Incontinence, Urinary →
Covid19 — all drugs for Covid19 →
Pelvic Floor Muscle Weakness — all drugs for Pelvic Floor Muscle Weakness →

Sponsor

Centro Hospitalar De São João, E.P.E.

Who can join

Adults 18 to 65, female only, with Stress Urinary Incontinence or Incontinence, Urinary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Urinary incontinence (UI) is defined as any involuntary loss of urine. It affects a significant percentage of the population, mainly female, with a prevalence of 21.4% in Portuguese women, having a negative impact on quality of life and sexual function. About half presents with stress UI (SUI), followed by mixed UI (MUI), with isolated urgency UI being less common. Pelvic floor rehabilitiation is a first line treatment for SUI and MUI, however, it is not yet defined which is the best treatment program or the ideal strategies to improve adherence to it. Telerehabilitation assumed a leading role in the covid pandemic phase, although there are few studies on pelvic floor rehabilitation for UI, none in Portugal to date. The authors aim to evaluate the effectiveness of a hybrid program of pelvic floor rehabilitation in female patients with SUI and MUI with a predominance of SUI, including consultation and face-to-face sessions complemented with telerehabilitation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Hybrid-Telerehabilitation Versus a Conventional Program for Urinary Incontinence: a Randomized Trial during COVID-19 Pandemic.
Santiago M, Cardoso-Teixeira P, Pereira S, Firmino-Machado J, et al · · 2023 · cited 19× · PMID 35596802 · DOI 10.1007/s00192-022-05108-6

Verify or expand the search:

Other recruiting trials for Stress Urinary Incontinence

Currently open trials in the same condition.

NCT06706362 — Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study) · Phase 4 · recruiting
NCT06924450 — Effect of Modified Mesh on Surgical Success in Transobturator Tape Surgery · NA · recruiting
NCT06840093 — Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial · NA · recruiting
NCT06111209 — The Anabolic Effect of Testosterone on Pelvic Floor Muscles · Phase 2 · recruiting
NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting

Other Centro Hospitalar De São João, E.P.E. trials

Trials by the same sponsor.

NCT06015373 — The Impact of Carvedilol Posology on Clinically Significant Portal Hypertension · NA · completed
NCT07065734 — NEgative prEssure Wound Therapy in Renal Transplant · Phase 4 · recruiting
NCT07411326 — Does Intraoperative Application of Steroids Affect Early Outcomes in Patients Undergoing Endoscopic Lumbar Discectomy? · NA · completed
NCT05321680 — Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD) · NA · completed
NCT05360199 — Are Postoperative Patient PROMS Influenced by Recall of Preoperative Scores? · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05114395 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centro Hospitalar De São João, E.P.E.
Last refreshed: 10 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05114395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing